BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31201478)

  • 1. Toward an animal model of borderline personality disorder.
    Corniquel MB; Koenigsberg HW; Likhtik E
    Psychopharmacology (Berl); 2019 Aug; 236(8):2485-2500. PubMed ID: 31201478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review.
    Zimmerman DJ; Choi-Kain LW
    Harv Rev Psychiatry; 2009; 17(3):167-83. PubMed ID: 19499417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of basal cortisol levels in Borderline Personality Disorder compared to non-psychiatric controls.
    Thomas N; Gurvich C; Hudaib AR; Gavrilidis E; Kulkarni J
    Psychoneuroendocrinology; 2019 Apr; 102():149-157. PubMed ID: 30557762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hypothalamus-Pituitary-Adrenal Axis and Social Cognition in Borderline Personality Disorder.
    Kulakova E; Graumann L; Wingenfeld K
    Curr Neuropharmacol; 2024; 22(3):378-394. PubMed ID: 37539934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid regulation of T cell function appears unaltered in borderline personality disorder.
    Fischer A; Grundmann J; Gold SM; Spitzer C; Wingenfeld K
    J Pers Disord; 2015 Apr; 29(2):241-7. PubMed ID: 25248018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline personality disorder and emotion dysregulation.
    Chapman AL
    Dev Psychopathol; 2019 Aug; 31(3):1143-1156. PubMed ID: 31169118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter.
    Rausch J; Gäbel A; Nagy K; Kleindienst N; Herpertz SC; Bertsch K
    Psychoneuroendocrinology; 2015 May; 55():116-27. PubMed ID: 25796037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress.
    Aleknaviciute J; Tulen JH; Kamperman AM; de Rijke YB; Kooiman CG; Kushner SA
    Psychoneuroendocrinology; 2016 Oct; 72():131-8. PubMed ID: 27413994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder.
    Nater UM; Bohus M; Abbruzzese E; Ditzen B; Gaab J; Kleindienst N; Ebner-Priemer U; Mauchnik J; Ehlert U
    Psychoneuroendocrinology; 2010 Nov; 35(10):1565-72. PubMed ID: 20630661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotion dysregulation as a maintenance factor of borderline personality disorder features.
    Stepp SD; Scott LN; Morse JQ; Nolf KA; Hallquist MN; Pilkonis PA
    Compr Psychiatry; 2014 Apr; 55(3):657-66. PubMed ID: 24342056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline personality disorder and multidimensional impulsivity: The roles of positive and negative emotion dysregulation.
    Waite EE; DeFontes C; Weiss NH; Karnedy C; Woods SE; Haliczer LA; Dixon-Gordon KL
    J Affect Disord; 2024 Jan; 344():635-643. PubMed ID: 37832740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder.
    Martín-Blanco A; Ferrer M; Soler J; Arranz MJ; Vega D; Calvo N; Elices M; Sanchez-Mora C; García-Martinez I; Salazar J; Carmona C; Bauzà J; Prat M; Pérez V; Pascual JC
    Eur Arch Psychiatry Clin Neurosci; 2016 Jun; 266(4):307-16. PubMed ID: 26182893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Borderline personality disorder in the light of developmental psychopathology].
    Mezei J; Juhasz A; Kilencz T; Vizin G
    Neuropsychopharmacol Hung; 2020 Sep; 22(3):102-111. PubMed ID: 33055291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline personality disorder: hypothalamus pituitary adrenal axis and findings from neuroimaging studies.
    Wingenfeld K; Spitzer C; Rullkötter N; Löwe B
    Psychoneuroendocrinology; 2010 Jan; 35(1):154-70. PubMed ID: 19837517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, personality, and neurodevelopmental phenotypes in borderline personality disorder: a family study.
    Ruocco AC; Daros AR; Chang J; Rodrigo AH; Lam J; Ledochowski J; McMain SF
    Psychol Med; 2019 Sep; 49(12):2069-2080. PubMed ID: 30303056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental psychopathology and neurobiology of aggression.
    Gollan JK; Lee R; Coccaro EF
    Dev Psychopathol; 2005; 17(4):1151-71. PubMed ID: 16613435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional dysregulation in borderline personality disorder and its influence on communication behavior and feelings in romantic relationships.
    Miano A; Grosselli L; Roepke S; Dziobek I
    Behav Res Ther; 2017 Aug; 95():148-157. PubMed ID: 28646782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is It Personal? Context Moderates BPD Effects on Spontaneous Rumination and Distress.
    Napolitano S; Yaroslavsky I; France CM
    J Pers Disord; 2020 Apr; 34(2):161-180. PubMed ID: 30179581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient Amygdala Habituation to Threatening Stimuli in Borderline Personality Disorder Relates to Adverse Childhood Experiences.
    Bilek E; Itz ML; Stößel G; Ma R; Berhe O; Clement L; Zang Z; Robnik L; Plichta MM; Neukel C; Schmahl C; Kirsch P; Meyer-Lindenberg A; Tost H
    Biol Psychiatry; 2019 Dec; 86(12):930-938. PubMed ID: 31366446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-examining borderline personality disorder and substance use disorder: The role of emotion dysregulation.
    Snow MB; Balling C; Zimmerman M
    Ann Clin Psychiatry; 2020 Aug; 32(3):170-175. PubMed ID: 32343289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.